Sectors / Medical

Medicine knows more than any person can hold — and much of it conflicts.

Clinical trials, research papers, molecular databases, guidelines, and real-world outcomes evolve at different speeds. We connect the evidence, grade its strength, and preserve the uncertainty that decisions depend on.

Research

Medical evidence is split across publications, registries, molecular databases, clinical guidance, and real-world records. Results may fail to replicate, measure different endpoints, or apply only to the population originally studied.

A useful medical knowledge base must show not only the current answer, but why it is believed, where it does not generalize, and what evidence would change it. Uncertainty is part of the record, not something to hide.

Questions Worth a Clean Answer

Ask hard. Answer with clean data.

  • Q01Which widely repeated findings still hold after retractions, failed replications, and population differences are accounted for?
  • Q02When trial results and real-world outcomes disagree, which differences in population, protocol, or measurement explain the gap?
  • Q03Which drug, gene, disease, and phenotype relationships are implied across studies but have not been examined directly?

The Method — A Continual Loop

Gather, organize, refine, test, prioritize — repeat.

01 · Gather

Collect the evidence base.

Ingest trials, papers, registries, molecular data, guidelines, and de-identified outcomes.

02 · Organize

Link claims to evidence.

Connect interventions, populations, endpoints, mechanisms, and source provenance.

03 · Refine

Grade what holds up.

Merge duplicate findings, expose contradictions, and weight evidence by quality and relevance.

04 · Test

Check against new outcomes.

Evaluate claims on held-out cohorts, later trials, simulations, and real-world results where appropriate.

05 · Prioritize

Surface consequential gaps.

Rank findings and unanswered questions by clinical importance, urgency, and confidence.

The Cascade

Drug Repurposing Cascades.

How compounds discovered for one indication cascade through their real mechanisms into unexpected therapeutic uses — and reshape entire markets. A map of serendipity turned into pipeline strategy for 2026.

Compound / insight
Mechanism
Repurposed use
Industry shift
Sildenafil
GLP-1 agonists
Minoxidil
Aspirin
Thalidomide
Botulinum toxin
Metformin
Ketamine
Naltrexone
SGLT2 inhibitors
Statins
Semaglutide
Rapamycin
Propranolol
Finasteride
Colchicine
Spironolactone
Doxycycline
Vasodilation
Satiety signaling
Follicle perfusion
Platelet inhibition
Anti-angiogenesis
Neuromuscular blockade
AMPK activation
NMDA antagonism
Opioid receptor block
Renal glucose excretion
Cholesterol lowering
mTOR inhibition
Beta-adrenergic block
DHT suppression
Inflammasome inhibition
Erectile dysfunction
Pulmonary hypertension
Obesity treatment
Cardiovascular prevention
Colorectal cancer
Hair regrowth
Multiple myeloma
Chronic migraine
Cosmetic aesthetics
Longevity therapy
Resistant depression
Addiction treatment
NASH/MASH
Heart failure
Performance anxiety
Chronic kidney disease
Blockbuster franchises
Consumer wellness
Dermatology market
Longevity market
Generics repurposing
Telehealth boom
Direct-to-consumer pharma
Oncology pipelines
Neuropsychiatry revival
Cardiometabolic care
Medical aesthetics
Payer formulary shift

Select any node to trace its chain. Left to right: Compound / insight → Mechanism → Repurposed use → Industry shift.

What the Core Delivers

Knowledge you can act on.

  • An evidence-graded medical record with claims linked directly to sources and populations.
  • Contradictions, generalization limits, and research gaps made explicit.
  • A prioritized set of hypotheses and evidence needs for researchers and care organizations.